- Adobe Inc.’s (ADBE) shares tumbled 7.6%, after the corporate introduced that its longtime CEO Shantanu Narayen will step down as soon as a successor is appointed.
- Shares of Meta Platforms Inc. (META) slid 3.8% following information that the corporate has delayed the discharge of its new AI mannequin “Avocado” to no less than Might.
- Shares of Nektar Therapeutics (NKTR) surged 4.1% after reporting fourth-quarter 2025 adjusted lack of $1.78 per share, narrower than the Zacks Consensus Estimate of an adjusted lack of $2.76 per share.
- Oruka Therapeutics Inc.’s (ORKA) shares soared 25% after posting fourth-quarter 2025 adjusted lack of $0.45 per share, narrower than the Zacks Consensus Estimate of an adjusted lack of $0.61 per share.
Zacks’ Analysis Chief Picks Inventory Most More likely to “At Least Double”
Our specialists have revealed their High 5 suggestions with money-doubling potential – and Director of Analysis Sheraz Mian believes one is superior to the others. After all, all our picks aren’t winners however this one might far surpass earlier suggestions like Hims & Hers Well being, which shot up +209%.
See Our High Inventory to Double (Plus 4 Runners Up) >>
Adobe Inc. (ADBE) : Free Inventory Evaluation Report
Nektar Therapeutics (NKTR) : Free Inventory Evaluation Report
Meta Platforms, Inc. (META) : Free Inventory Evaluation Report
Oruka Therapeutics, Inc. (ORKA) : Free Inventory Evaluation Report
This text initially printed on Zacks Funding Analysis (zacks.com).
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially replicate these of Nasdaq, Inc.
